Generation of H-2 Restricted Cytotoxic T Cells by Trinitrophenylated Proteins in Vitro: Specificity and Requirements
- 30 September 1979
- journal article
- research article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 123 (4), 1696-1704
- https://doi.org/10.4049/jimmunol.123.4.1696
Abstract
Addition of TNBS-conjugated soluble proteins to cultures of murine spleen cells, of the H-2k haplotype, led to the generation of MHC-restricted cytotoxic T cells. This phenomenon was effected by a wide range of proteins including ovalbumin, bovine γ-globulin, bovine serum albumin, human γ-globulin, human serum albumin (TNP-HSA), and keyhold limpet hemocyanin. Cytotoxic T lymphocytes (CTL) generated in such manner showed specificity for the hapten rather than for the protein carrier, in that they lysed cells bearing hapten coupled to either heterologous or homologous carriers. Spleen cell populations incubated with soluble HSA substituted to various degrees (8–40 moles TNP/mole HSA) displayed TNP on their surface as evidenced by a) C-mediated lysis, and b) spectrophotometric measurement of solubilized cell membranes. However, only those cells bearing HSA substituted at more than 26 moles TNP/mole HSA were susceptible to lysis by hapten-specific H-2 restricted CTL. Furthermore, TNP-HSA with lower substitution (<26 mole/mole) did not stimulate hapten-specific cytotoxic responses. These observations illustrate several features of target cell recognition by hapten-specific, H-2 restricted, cytotoxic T-cells: i) These CTL do not show specificity to the protein carrier. In this regard cytotoxic T cells differ from T cells responsible for delayed-type hypersensitivity (DTH). ii) Hapten and H-2 need not be covalently linked. iii) Hapten display on the cell surface, even in relatively large amounts, is not in itself sufficient. Rather, it seems that some stringent requirements of protein derivatization and/or distribution have to be met irrespective of whether the protein substituted is intrinsic to the cell membrane or exogenously added. These findings represent a reproducible system for further investigation of the exact molecular nature of the antigenic determinants recognized by CTL.This publication has 11 references indexed in Scilit:
- Genetic control of cytolytic T-lymphocyte responses. I. Ir gene control of the specificity of cytolytic T-lymphocyte responses to trinitrophenyl-modified syngeneic cells.The Journal of Experimental Medicine, 1978
- H-2-restricted cytotoxic effectors generated in vitro by the addition of trinitrophenyl-conjugated soluble proteinsThe Journal of Experimental Medicine, 1978
- RELATIONSHIP BETWEEN TRINITROPHENOL AND H-2 ANTIGENS ON TRINITROPHENYL-MODIFIED SPLEEN-CELLS .3. QUANTITATIVE ASPECTS OF TRINITROPHENOL BINDING ON CELLS TREATED WITH TRINITROBENZENE SULFONIC-ACID1978
- Specificity of cytotoxic effector cells directed against trinitrobenzene sulfonate-modified syngeneic cells. Failure to recognize cell surface- bound trinitrophenyl dextranThe Journal of Experimental Medicine, 1977
- Antigen Recognition: The Specificity of an Isolated T Lymphocyte PopulationThe Journal of Immunology, 1977
- RELATIONSHIP BETWEEN TRINITROPHENYL AND H-2 ANTIGENS ON TRINITROPHENYL-MODIFIED SPLEEN-CELLS .2. CORRELATION BETWEEN DERIVATIZATION OF H-2 ANTIGENS WITH TRINITROPHENYL AND ABILITY OF TRINITROPHENYL-MODIFIED CELLS TO REACT FUNCTIONALLY IN CML ASSAY1977
- RELATIONSHIP BETWEEN TRINITROPHENYL AND H-2 ANTIGENS ON TRINITROPHENYL-MODIFIED SPLEEN-CELLS .1. H-2 ANTIGENS ON CELLS TREATED WITH TRINITROBENZENE SULFONIC-ACID ARE DERIVATIZED1977
- Cross-reactive lysis of trinitrophenyl (TNP)-derivatized H-2 incompatible target cells by cytolytic T lymphocytes generated against syngeneic TNP spleen cells.The Journal of Experimental Medicine, 1976
- Cell-mediated lympholysis to H-2-matched target cells modified with a series of nitrophenyl compounds.The Journal of Experimental Medicine, 1976
- IMMUNOLOGICAL SPECIFICITY OF DELAYED AND IMMEDIATE HYPERSENSITIVITY REACTIONSThe Journal of Experimental Medicine, 1962